October 25, 2024

VMS Industry Valuation Update - Q1 2024

Our comprehensive analysis of the Vitamins, Minerals & Supplements sector reveals steady growth amid increasing competition:

Market Performance

·        11% stock appreciation over last 12 months

·        Continued high health awareness driving consistent demand

·        Market maturity reflected in conservative investor sentiment

Valuation Metrics

·        Industry multiples at EV/Revenue of 1.2x and EV/EBITDA of 8.4x

·        M&A transactions showing median EV/Revenue multiple of 1.9x

·        Detailed analysis of growth versus profitability impact on valuations

Market Dynamics

·        Steady growth despite increasing market saturation

·        Strong shelf space control maintaining barriers to entry

·        Comprehensive review of recent strategic acquisitions

Strategic Considerations

·        Focus shift from growth to profitability metrics

·        Key performance indicators driving valuations

·        In-depth analysis of strategic and financial buyer landscape

 

To access the full report, reach out to niklas@exitace.com